Wanbangde Pharmaceutical Holding Group Co., Ltd. engages in the research and development, production, and sale of traditional Chinese medicine, chemical raw materials, and chemical preparations in China and internationally. The company operates through two segments, the Pharmaceutical Manufacturing Business and the Medical Device Business. It offers drugs products used to treat cardiovascular and cerebrovascular diseases; and nervous, respiratory, mental, and digestive system diseases. The company also develops and sells human orthopedic implant devices, including orthopedic implant devices comprised of thoracolumbar fusion, cervical fusion, spinal internal fixation systems, independent fusion devices, unicompartmental knee joints, etc.; medical equipment; disposable sterile medical polymer consumables; and hospital engineering services. The company was formerly known as Wanbangde New Building Materials Co., Ltd. and changed its name to Wanbangde Pharmaceutical Holding Group Co., Ltd. in April 2020. Wanbangde Pharmaceutical Holding Group Co., Ltd. was founded in 1985 and is headquartered in Taizhou, China. Address: No. 28, Baizhang North Road, Taizhou, China, 317500